Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.

Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.

The search for an efficacious vaccine against malaria is ongoing, and it is now widely believed that to confer protection a vaccine must induce very strong cellular and humoral immunity concurrently. We studied the immune response in mice immunized with the recombinant viral vaccines fowlpox strain...

Полное описание

Библиографические подробности
Главные авторы:	Hutchings, C, Birkett, A, Moore, A, Hill, A
Формат:	Journal article
Язык:	English
Опубликовано:	2007

Схожие документы

Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity.
по: Hutchings, C, и др.
Опубликовано: (2005)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
по: Tully, C, и др.
Опубликовано: (2017)

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
по: Moon, James J., и др.
Опубликовано: (2013)

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.
по: Lalvani, A, и др.
Опубликовано: (1999)

Humoral and cellular immunity to RSV in infants, children and adults
по: Green, C, и др.
Опубликовано: (2018)

The humoral immune response to BCG vaccination
по: Tanner, R, и др.
Опубликовано: (2019)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
по: Draper, S, и др.
Опубликовано: (2005)

Cellular basis of the humoral immune response in mouse and hamster.
по: Erb, P, и др.
Опубликовано: (1978)

The temporal dynamics of humoral immunity to Rickettsia typhi infection in murine typhus patients
по: Phakhounthong, K, и др.
Опубликовано: (2019)

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
по: Parren, P, и др.
Опубликовано: (1999)

Quantitative PCR evaluation of cellular immune responses in kenyan children vaccinated with a candidate malaria vaccine
по: Mwacharo, J, и др.
Опубликовано: (2009)

Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.
по: Mwacharo, J, и др.
Опубликовано: (2009)

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity to bacterial, viral and parasitic antigens: increased durable cellular immunity with reduced immunodominance
по: Moore, A, и др.
Опубликовано: (2005)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
по: Ewer, K, и др.
Опубликовано: (2015)

Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
по: Oxenius, A, и др.
Опубликовано: (1998)

Contribution of humoral immunity to the therapeutic response in falciparum malaria.
по: Mayxay, M, и др.
Опубликовано: (2001)

Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults
по: Green, C, и др.
Опубликовано: (2019)

Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.
по: Draper, S, и др.
Опубликовано: (2009)

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses
по: Antrobus, R, и др.
Опубликовано: (2014)

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses.
по: Antrobus, R, и др.
Опубликовано: (2014)

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
по: Lopes, A, и др.
Опубликовано: (2018)

Vaccines against intracellular infections requiring cellular immunity.
по: Seder, R, и др.
Опубликовано: (2000)

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.
по: Colloca, S, и др.
Опубликовано: (2012)

Viral escape and the failure of cellular immune responses.
по: Klenerman, P, и др.
Опубликовано: (2000)

Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults.
по: Leroux-Roels, I, и др.
Опубликовано: (2009)

Large Scale Agent-Based Modeling of the Humoral and Cellular Immune Response
по: Stracquadanio, Giovanni, и др.
Опубликовано: (2016)

One-year sustained cellular and humoral immunities of COVID-19 convalescents
по: Zhang, J, и др.
Опубликовано: (2021)

Viral vectors for malaria vaccine development.
по: Li, S, и др.
Опубликовано: (2007)

Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.
по: Elias, S, и др.
Опубликовано: (2013)

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
по: Gilbert, S, и др.
Опубликовано: (2017)

Shaping humoral immunity to vaccines through antigen-displaying nanoparticles
по: Irvine, Darrell J, и др.
Опубликовано: (2020)

The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.
по: Cashman, S, и др.
Опубликовано: (2014)

Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.
по: Pinder, M, и др.
Опубликовано: (2004)

The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus.
по: de Cassan, S, и др.
Опубликовано: (2011)

Detectable vesicular stomatitis virus (VSV)–specific humoral and cellular immune responses following VSV–Ebola virus vaccination in humans
по: Poetsch, J, и др.
Опубликовано: (2018)

A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.
по: Beverley, P, и др.
Опубликовано: (2014)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
по: Venkatraman, N, и др.
Опубликовано: (2017)

Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
по: Forbes, E, и др.
Опубликовано: (2011)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
по: Pinpathomrat, N, и др.
Опубликовано: (2021)

Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination
по: Twumasi, C, и др.
Опубликовано: (2023)